GeorgeJourMDFACP

Pathology • New York, NY

Dermatopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Bone and soft tissue Pathology

Join to view full profile

Dr. Jour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jour's full profile

Already have an account?

Office
550 1st Ave
New York, NY 10016
Phone+1 212-263-5470

Fax+1 212-263-9701

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology, 2015 - 2016
Memorial Sloan Kettering Cancer CenterFellowship, Molecular Genetic Pathology, 2014 - 2015
University of Washington School of MedicineSelective Pathology, 2013 - 2014
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2008 - 2009
St Joseph's University Medical SchoolClass of 2007

Certifications & Licensure

NJ State Medical License 2016 - 2025
NY State Medical License 2013 - 2025
PA State Medical License 2017 - 2024
CT State Medical License 2019 - 2021
WA State Medical License 2012 - 2016
American Board of Dermatology Dermatopathology
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Dermatopathology
American Board of Pathology Pathology - Molecular Genetic
NYDOHCOQ Lab director for Molecular Oncology

Publications & Presentations

PubMed

26 citations
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas.
Lawrence Hsu Lin, Douglas H R Allison, Yang Feng, George Jour, Kyung En Park
Modern Pathology. 2021-08-06
75 citations
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma
Paul Johannet, Nicolas Coudray, Douglas Donnelly, George Jour, Irineu Illa-Bochaca
Clinical Cancer Research. 2021-01-01
3 citations
Pigmented Epithelioid Melanocytomas and Their Mimics; Focus on Their Novel Molecular Findings.
Erol C Bayraktar, George Jour
Biology. 2021-12-08

Journal Articles

Microglandular Adenosis Is an Advanced Precursor Breast Lesion with Evidence of Molecular Progression to Matrix-Producing Metaplastic Carcinoma
Esther Yoon, George Jour, Iman Osman, Diana Nimeh, Farbod Darvishian, ScienceDirect
BCAT1 and miR-2504: Novel Methylome Signature Distinguishes spindle/desmoplastic Melanoma from Superficial Malignant Peripheral Nerve Sheath Tumor
Erik P Sulman, Matija Snuderl, George Jour, Phyu P Aung, Nature

Press Mentions

Skin Cancer Cells - as They Spread to the Brain - Use an Alzheimer's Protein to Sabotage Immune DefensesMarch 9th, 2022
Innovative Health Diagnostics (IHD) Announces Location Expansion to New YorkSeptember 22nd, 2021

Professional Memberships

Other Languages

Arabic, French, Spanish